002550 千红制药
已收盘 03-10 15:00:00
资讯
新帖
简况
千红制药（002550）披露向不特定对象发行可转换公司债券募集说明书（修订稿），3月10日股价上涨1.19%
证券之星 · 03-10 22:40
千红制药（002550）披露向不特定对象发行可转换公司债券募集说明书（修订稿），3月10日股价上涨1.19%
股市必读：千红制药（002550）3月5日董秘有最新回复
证券之星 · 03-06
股市必读：千红制药（002550）3月5日董秘有最新回复
千红制药：依诺肝素、那屈肝素拟中选国家集采接续采购
证券之星 · 03-05
千红制药：依诺肝素、那屈肝素拟中选国家集采接续采购
股市必读：千红制药（002550）3月3日董秘有最新回复
证券之星 · 03-04
股市必读：千红制药（002550）3月3日董秘有最新回复
股市必读：千红制药（002550）2月27日董秘有最新回复
证券之星 · 03-02
股市必读：千红制药（002550）2月27日董秘有最新回复
千红制药：公司高度重视创新药研发及人才队伍建设
证券之星 · 02-12
千红制药：公司高度重视创新药研发及人才队伍建设
机器人概念普遍拉升 极智嘉(02590)升近7% 北京人形机器人创新中心融资7亿元
金吾财讯 · 02-10
机器人概念普遍拉升 极智嘉(02590)升近7% 北京人形机器人创新中心融资7亿元
千红制药：公司已于2026年1月26日披露了《关于向不特定对象发行可转换公司债券申请获得深交所受理的公告》
证券之星 · 02-05
千红制药：公司已于2026年1月26日披露了《关于向不特定对象发行可转换公司债券申请获得深交所受理的公告》
机器人概念表现分化 卧安机器人(06600)升近19% 机构料今年人形机器人将迎"0-1"兑现关键期
金吾财讯 · 01-28
机器人概念表现分化 卧安机器人(06600)升近19% 机构料今年人形机器人将迎"0-1"兑现关键期
千红制药（002550）披露向不特定对象发行可转换公司债券申请获深交所受理公告，1月26日股价上涨1.08%
证券之星 · 01-26
千红制药（002550）披露向不特定对象发行可转换公司债券申请获深交所受理公告，1月26日股价上涨1.08%
千红制药：创新药QHRD106、QHRD107有序推进临床试验
证券之星 · 01-19
千红制药：创新药QHRD106、QHRD107有序推进临床试验
千红制药（002550）披露调整向不特定对象发行可转换公司债券方案，12月10日股价上涨0.25%
证券之星 · 2025-12-10
千红制药（002550）披露调整向不特定对象发行可转换公司债券方案，12月10日股价上涨0.25%
千红制药：创新药项目正有序推进临床试验
证券之星 · 2025-12-02
千红制药：创新药项目正有序推进临床试验
千红制药：暂未收到大股东减持计划
证券之星 · 2025-11-26
千红制药：暂未收到大股东减持计划
千红制药：11月21日高管赵刚减持股份合计142.95万股
证券之星 · 2025-11-24
千红制药：11月21日高管赵刚减持股份合计142.95万股
千红制药：11月20日高管赵刚减持股份合计461.8万股
证券之星 · 2025-11-21
千红制药：11月20日高管赵刚减持股份合计461.8万股
千红制药（002550）披露实施2025年员工持股计划，11月11日股价上涨0.11%
证券之星 · 2025-11-11
千红制药（002550）披露实施2025年员工持股计划，11月11日股价上涨0.11%
股市必读：千红制药（002550）11月7日董秘有最新回复
证券之星 · 2025-11-10
股市必读：千红制药（002550）11月7日董秘有最新回复
千红制药：尚未收到股东减持进展通知
证券之星 · 2025-11-07
千红制药：尚未收到股东减持进展通知
千红制药（002550）2025年三季报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 2025-10-31
千红制药（002550）2025年三季报简析：营收净利润同比双双增长，盈利能力上升
公司概况
公司名称：
常州千红生化制药股份有限公司
所属行业：
医药制造业
上市日期：
2011-02-18
主营业务：
常州千红生化制药股份有限公司的主营业务是药物研发、生产和应用。公司的主要产品是胰激肽原酶系列、复方消化酶胶囊（Ⅱ）、门冬酰胺酶系列和弹性酶、肝素钠及低分子肝素类系列。公司是国家级高新技术企业。
发行价格：
32.00
{"stockData":{"symbol":"002550","market":"SZ","secType":"STK","nameCN":"千红制药","latestPrice":7.63,"timestamp":1773126222000,"preClose":7.54,"halted":0,"volume":10576323,"delay":0,"changeRate":0.0119,"floatShares":941000000,"shares":1280000000,"eps":0.3358,"marketStatus":"已收盘","change":0.09,"latestTime":"03-10 15:00:00","open":7.57,"high":7.65,"low":7.55,"amount":80373900,"amplitude":0.0133,"askPrice":7.64,"askSize":2715,"bidPrice":7.63,"bidSize":144,"shortable":0,"etf":0,"ttmEps":0.3358,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1773192600000},"marketStatusCode":5,"adr":0,"adjPreClose":7.54,"symbolType":"stock","openAndCloseTimeList":[[1773106200000,1773113400000],[1773118800000,1773126000000]],"highLimit":8.29,"lowLimit":6.79,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1279800000,"isCdr":false,"pbRate":3.51,"roa":"--","peRate":22.721858,"roe":"14.5%","epsLYR":0.28,"committee":-0.267838,"marketValue":9765000000,"turnoverRate":0.0112,"status":0,"floatMarketCap":7182000000},"requestUrl":"/m/hq/s/002550/wiki","defaultTab":"wiki","newsList":[{"id":"2618951184","title":"千红制药（002550）披露向不特定对象发行可转换公司债券募集说明书（修订稿），3月10日股价上涨1.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618951184","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618951184?lang=zh_cn&edition=full","pubTime":"2026-03-10 22:40","pubTimestamp":1773153628,"startTime":"0","endTime":"0","summary":"截至2026年3月10日收盘，千红制药报收于7.63元，较前一交易日上涨1.19%，最新总市值为97.65亿元。该股当日开盘7.57元，最高7.65元，最低7.55元，成交额达8037.39万元，换手率为1.12%。近日，千红制药披露《向不特定对象发行可转换公司债券并在主板上市募集说明书（修订稿）》。公告显示，本次发行可转债总额不超过10亿元，用于创新药研发、湖北钟祥原料药生产基地建设及补充流动资金。本次可转债信用等级为AA，不设担保。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031000038620.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002550"],"gpt_icon":0},{"id":"2617527069","title":"股市必读：千红制药（002550）3月5日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2617527069","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617527069?lang=zh_cn&edition=full","pubTime":"2026-03-06 02:07","pubTimestamp":1772734031,"startTime":"0","endTime":"0","summary":"截至2026年3月5日收盘，千红制药报收于7.35元，上涨0.55%，换手率1.24%，成交量11.63万手，成交额8568.29万元。董秘最新回复投资者： 请问:公司的产品有没有中选国家集采药品接续釆购？如有为何不发布公告？当日关注点来自交易信息汇总：3月5日主力资金净流入76.93万元，游资积极介入，散户资金呈净流出态势。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030600001097.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002550"],"gpt_icon":0},{"id":"2617594339","title":"千红制药：依诺肝素、那屈肝素拟中选国家集采接续采购","url":"https://stock-news.laohu8.com/highlight/detail?id=2617594339","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617594339?lang=zh_cn&edition=full","pubTime":"2026-03-05 11:46","pubTimestamp":1772682374,"startTime":"0","endTime":"0","summary":"证券之星消息，千红制药(002550)03月05日在投资者关系平台上答复投资者关心的问题。投资者提问：请问:公司的产品有没有中选国家集采药品接续釆购？如有为何不发布公告？千红制药回复：尊敬的投资者，您好，公司依诺肝素、那屈肝素参与了第1-8批国家组织集采药品协议期满品种接续采购并拟中选，具体中选情况烦请详询国家组织集采药品协议期满品种接续采购办公室发布的公示文件，公司将严格按照监管要求履行信息披露义务，如涉及应披露事项将及时公告。感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030500016572.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002550","BK0239"],"gpt_icon":0},{"id":"2616783153","title":"股市必读：千红制药（002550）3月3日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2616783153","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616783153?lang=zh_cn&edition=full","pubTime":"2026-03-04 01:49","pubTimestamp":1772560149,"startTime":"0","endTime":"0","summary":"截至2026年3月3日收盘，千红制药报收于7.38元，下跌2.12%，换手率1.96%，成交量18.47万手，成交额1.37亿元。董秘最新回复投资者： 请问公司作为上市公众公司为什么不及时披露关键信息？交易信息汇总资金流向3月3日主力资金净流出3252.53万元；游资资金净流入707.0万元；散户资金净流入2545.53万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030400000997.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002550"],"gpt_icon":0},{"id":"2616232875","title":"股市必读：千红制药（002550）2月27日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2616232875","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616232875?lang=zh_cn&edition=full","pubTime":"2026-03-02 02:21","pubTimestamp":1772389270,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，千红制药报收于7.79元，下跌0.26%，换手率0.87%，成交量8.19万手，成交额6376.17万元。董秘最新回复投资者： 董秘请问:公司近期和天目湖健康研究院启签订的战略合作为什么不见有公告呢？当日关注点来自交易信息汇总：2月27日主力资金净流出714.07万元，显示主力短期减持动向。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200001068.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002550"],"gpt_icon":0},{"id":"2610914625","title":"千红制药：公司高度重视创新药研发及人才队伍建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2610914625","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610914625?lang=zh_cn&edition=full","pubTime":"2026-02-12 15:06","pubTimestamp":1770879979,"startTime":"0","endTime":"0","summary":"证券之星消息，千红制药02月12日在投资者关系平台上答复投资者关心的问题。目前公司的人才招聘是不是太保守了？感谢您对公司的关注。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021200018920.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK1161","BK0239","002550","159992","06978"],"gpt_icon":0},{"id":"2610561386","title":"机器人概念普遍拉升 极智嘉(02590)升近7% 北京人形机器人创新中心融资7亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610561386","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610561386?lang=zh_cn&edition=full","pubTime":"2026-02-10 14:04","pubTimestamp":1770703452,"startTime":"0","endTime":"0","summary":"金吾财讯 | 机器人概念普遍拉升，极智嘉 升6.92%，微创机器人升4.74%，三花智控升3.39%，地平线机器人升3.39%，越疆升2.65%，优必选升2.28%。消息面上，近日，北京人形机器人创新中心宣布完成首轮市场化融资，规模突破7亿元，标志着其正式步入市场化运营与产业化落地并行的新阶段。","market":"sg","thumbnail":"https://static.szfiu.com/news/20250110/MjA1YmE2ZTUwNGJlNDY3ODMxMDE0ODI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MjA1YmE2ZTUwNGJlNDY3ODMxMDE0ODI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"d9041278c534c319147028b8bffb7e28","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974869","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348767384.USD","SG9999011746.SGD","LU0164939612.USD","02050","002550","300024","LU0348766576.USD","BK1613","LU0620787316.HKD","LU0274383008.USD","02590","BK1617","BK1109","09880","LU0082770016.USD","09660","002050","02432","LU0082770016.SGD","BK1183","BK1100","02252"],"gpt_icon":0},{"id":"2609215873","title":"千红制药：公司已于2026年1月26日披露了《关于向不特定对象发行可转换公司债券申请获得深交所受理的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2609215873","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609215873?lang=zh_cn&edition=full","pubTime":"2026-02-05 15:48","pubTimestamp":1770277699,"startTime":"0","endTime":"0","summary":"证券之星消息，千红制药(002550)02月05日在投资者关系平台上答复投资者关心的问题。投资者提问：请问一下你们家还有发行可转债吗？怎么一点动静都没有？千红制药回复：尊敬的投资者您好，公司已于2026年1月26日披露了《关于向不特定对象发行可转换公司债券申请获得深交所受理的公告》（公告编号：2026-001）以及募集说明书等相关公告文件，目前可转债发行相关工作正在积极有序推进中，具体发行进展请以公司后续公告为准。感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020500021146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002550","BK0239"],"gpt_icon":0},{"id":"2606064767","title":"机器人概念表现分化 卧安机器人(06600)升近19% 机构料今年人形机器人将迎\"0-1\"兑现关键期","url":"https://stock-news.laohu8.com/highlight/detail?id=2606064767","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606064767?lang=zh_cn&edition=full","pubTime":"2026-01-28 14:52","pubTimestamp":1769583138,"startTime":"0","endTime":"0","summary":"金吾财讯 | 机器人概念表现分化，卧安机器人 升18.71%，港仔机器人升4.44%，优必选升2.34%，地平线机器人升0.23%；跌幅方面，云迹跌3.17%，微创机器人跌1.62%，速腾聚创、三花智控跌逾1%，越疆跌0.8%。汤道生指出，中国激烈的竞争环境倒逼企业加速技术迭代与应用落地，这种在“真实场景”中打磨出的竞争力尚未被市场充分定价。国金证券指出，26年是人形机器人0-1兑现的重要节点。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/YjNiOTNjODIxNjM4MTUzMTI5MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YjNiOTNjODIxNjM4MTUzMTI5MQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1974112","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1181","02432","00370","06600","BK1617","BK1100","02252","BK1179","BK1191","BK1613","BK1214","SG9999011746.SGD","BK1109","02498","BK1183","002550","002050","02670"],"gpt_icon":1},{"id":"2606219186","title":"千红制药（002550）披露向不特定对象发行可转换公司债券申请获深交所受理公告，1月26日股价上涨1.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606219186","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606219186?lang=zh_cn&edition=full","pubTime":"2026-01-26 18:28","pubTimestamp":1769423332,"startTime":"0","endTime":"0","summary":"截至2026年1月26日收盘，千红制药报收于8.39元，较前一交易日上涨1.08%，最新总市值为107.38亿元。千红制药于近日发布《关于向不特定对象发行可转换公司债券申请获得深交所受理的公告》。公告显示，公司于2026年1月23日收到深圳证券交易所出具的通知，其向不特定对象发行可转换公司债券的申请文件已被深交所受理。该事项尚需通过深交所审核，并获得中国证券监督管理委员会同意注册的批复后方可实施，最终能否获批及时间存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600025413.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002550"],"gpt_icon":0},{"id":"2604186030","title":"千红制药：创新药QHRD106、QHRD107有序推进临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2604186030","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2604186030?lang=zh_cn&edition=full","pubTime":"2026-01-19 16:12","pubTimestamp":1768810367,"startTime":"0","endTime":"0","summary":"证券之星消息，千红制药(002550)01月19日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘请问:公司的106/107创新药申请进入期临床是不是遇到重大问题，从而造成久拖不决局面？千红制药回复：尊敬的投资者，您好，公司原创一类创新药物QHRD106、QHRD107目前均处于有序推进临床试验的过程中，公司将按照CDE的要求全力推进新药研发进程，相关进展将严格遵循法规披露要求，感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011900017416.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06978","BK1574","BK1161","BK0239","002550","159992"],"gpt_icon":0},{"id":"2590353898","title":"千红制药（002550）披露调整向不特定对象发行可转换公司债券方案，12月10日股价上涨0.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590353898","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590353898?lang=zh_cn&edition=full","pubTime":"2025-12-10 22:08","pubTimestamp":1765375693,"startTime":"0","endTime":"0","summary":"截至2025年12月10日收盘，千红制药报收于8.07元，较前一交易日上涨0.25%，最新总市值为103.28亿元。近日，千红制药发布公告称，公司于2025年12月10日召开2025年第二次临时股东会，会议审议通过了关于调整公司向不特定对象发行可转换公司债券方案的议案。公告显示，此次股东大会出席会议的股东共548人，代表股份501,287,280股，占公司有表决权股份总数的40.1094%。包括本次调整方案在内的七项相关议案均获得出席股东所持有效表决权三分之二以上通过。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121000041093.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002550"],"gpt_icon":0},{"id":"2588874440","title":"千红制药：创新药项目正有序推进临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2588874440","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588874440?lang=zh_cn&edition=full","pubTime":"2025-12-02 15:09","pubTimestamp":1764659356,"startTime":"0","endTime":"0","summary":"证券之星消息，千红制药12月02日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘请问:公司过几天就召开股东大会为创新药募资发债投票表决了，是不是应该公布106/107这两个创新药的期临床数据给持股的投资者看看和评估？千红制药回复：尊敬的投资者，您好，公司创新药项目QHRD106、QHRD107目前均处于有序推进临床试验的过程中，相关进展将严格遵循法规披露要求，公司将在定期报告及相关公告中及时披露重大研发进展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200016948.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159992","BK0239","002550","06978","BK1161","BK1574"],"gpt_icon":0},{"id":"2586523002","title":"千红制药：暂未收到大股东减持计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2586523002","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586523002?lang=zh_cn&edition=full","pubTime":"2025-11-26 20:52","pubTimestamp":1764161538,"startTime":"0","endTime":"0","summary":"证券之星消息，千红制药(002550)11月26日在投资者关系平台上答复投资者关心的问题。投资者提问：大股东的减持，对股票的波动造成很大的影响。请问大股东减持结束后，要过多长时间才能继续减持？千红制药回复：尊敬的投资者，您好，目前公司暂未收到大股东的减持计划，后续如公司收到大股东的减持告知函，将按证监会、深交所相关规定履行信息披露义务。感谢您对公司的关注，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600035808.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002550","BK0239"],"gpt_icon":0},{"id":"2585462148","title":"千红制药：11月21日高管赵刚减持股份合计142.95万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2585462148","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585462148?lang=zh_cn&edition=full","pubTime":"2025-11-24 21:01","pubTimestamp":1763989305,"startTime":"0","endTime":"0","summary":"证券之星消息，根据11月24日市场公开信息、上市公司公告及交易所披露数据整理，千红制药（002550）最新董监高及相关人员股份变动情况：2025年11月21日公司董事赵刚共减持公司股份142.95万股，占公司总股本为0.1117%。变动期间公司股价下跌3.28%，11月21日当日收盘报8.25元。千红制药近半年内的董监高及核心技术人员增减持详情如下：千红制药的高管列表及最新持股情况如下：该股最近90天内共有2家机构给出评级，买入评级1家，增持评级1家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400032840.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002550","BK0239"],"gpt_icon":0},{"id":"2585908143","title":"千红制药：11月20日高管赵刚减持股份合计461.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2585908143","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585908143?lang=zh_cn&edition=full","pubTime":"2025-11-21 21:02","pubTimestamp":1763730129,"startTime":"0","endTime":"0","summary":"证券之星消息，根据11月21日市场公开信息、上市公司公告及交易所披露数据整理，千红制药（002550）最新董监高及相关人员股份变动情况：2025年11月20日公司董事赵刚共减持公司股份461.8万股，占公司总股本为0.3608%。变动期间公司股价下跌0.12%，11月20日当日收盘报8.53元。千红制药近半年内的董监高及核心技术人员增减持详情如下：千红制药的高管列表及最新持股情况如下：该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100037388.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002550"],"gpt_icon":0},{"id":"2582592367","title":"千红制药（002550）披露实施2025年员工持股计划，11月11日股价上涨0.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582592367","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582592367?lang=zh_cn&edition=full","pubTime":"2025-11-11 22:27","pubTimestamp":1762871244,"startTime":"0","endTime":"0","summary":"截至2025年11月11日收盘，千红制药报收于9.19元，较前一交易日上涨0.11%，最新总市值为117.61亿元。近日，千红制药发布关于实施2025年员工持股计划的相关公告。本次员工持股计划参加对象不超过60人，资金来源为员工自筹，股票来源为公司回购股份，存续期不超过48个月，遵循自愿参与、风险自担原则，不涉及财务资助或一致行动安排。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100040929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002550","BK0239"],"gpt_icon":0},{"id":"2582474818","title":"股市必读：千红制药（002550）11月7日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2582474818","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582474818?lang=zh_cn&edition=full","pubTime":"2025-11-10 02:17","pubTimestamp":1762712232,"startTime":"0","endTime":"0","summary":"截至2025年11月7日收盘，千红制药报收于9.09元，上涨0.33%，换手率2.04%，成交量19.19万手，成交额1.74亿元。董秘最新回复投资者： 董秘，您好！大股东赵刚公布减持股份已进入第3个月，请公布其目前已实施减持的股份数量。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111000000887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002550"],"gpt_icon":0},{"id":"2581888886","title":"千红制药：尚未收到股东减持进展通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2581888886","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581888886?lang=zh_cn&edition=full","pubTime":"2025-11-07 20:48","pubTimestamp":1762519735,"startTime":"0","endTime":"0","summary":"证券之星消息，千红制药(002550)11月07日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘，您好！大股东赵刚公布减持股份已进入第3个月，请公布其目前已实施减持的股份数量。千红制药回复：尊敬的投资者，您好，根据公司已披露的减持预披露公告（公告编号：2025-021），赵刚先生及其一致行动人减持计划将根据市场情况、公司股价等综合因素决定是否实施。截至目前，公司尚未收到该股东的减持进展通知，后续将严格履行信息披露义务。感谢您对公司的关注。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110700036456.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002550","BK0239"],"gpt_icon":0},{"id":"2579101648","title":"千红制药（002550）2025年三季报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2579101648","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579101648?lang=zh_cn&edition=full","pubTime":"2025-10-31 06:43","pubTimestamp":1761864230,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期千红制药发布2025年三季报。截至本报告期末，公司营业总收入12.15亿元，同比上升0.61%，归母净利润3.83亿元，同比上升23.79%。按单季度数据看，第三季度营业总收入3.53亿元，同比上升0.35%，第三季度归母净利润1.25亿元，同比下降1.28%。本报告期千红制药盈利能力上升，毛利率同比增幅6.84%，净利率同比增幅22.54%。持有千红制药最多的基金为博道中证1000指数增强A，目前规模为1.47亿元，最新净值1.5421，较上一交易日下跌1.43%，近一年上涨53.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100009579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002550"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1773160868316,"stockEarnings":[{"period":"1week","weight":0.0339},{"period":"1month","weight":-0.0317},{"period":"3month","weight":-0.0545},{"period":"6month","weight":-0.2362},{"period":"1year","weight":0.3758},{"period":"ytd","weight":-0.0293}],"compareEarnings":[{"period":"1week","weight":0.0001},{"period":"1month","weight":0.0142},{"period":"3month","weight":0.0571},{"period":"6month","weight":0.064},{"period":"1year","weight":0.2249},{"period":"ytd","weight":0.0389}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"常州千红生化制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"73615人(较上一季度增加1.17%)","perCapita":"12785股","listingDate":"2011-02-18","address":"江苏省常州市新北区云河路518号","registeredCapital":"127980万元","survey":" 常州千红生化制药股份有限公司的主营业务是药物研发、生产和应用。公司的主要产品是胰激肽原酶系列、复方消化酶胶囊（Ⅱ）、门冬酰胺酶系列和弹性酶、肝素钠及低分子肝素类系列。公司是国家级高新技术企业。","listedPrice":32},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"千红制药(002550)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供千红制药(002550)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"千红制药,002550,千红制药股票,千红制药股票老虎,千红制药股票老虎国际,千红制药行情,千红制药股票行情,千红制药股价,千红制药股市,千红制药股票价格,千红制药股票交易,千红制药股票购买,千红制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"千红制药(002550)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供千红制药(002550)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}